{
  "compound": "Medical cannabis and cannabinoids",
  "condition": "CANCER_PALLIATIVE",
  "effect_size": "N/A (guideline)",
  "study_type": "CLINICAL_GUIDELINE",
  "source": "NORML:CANCER_GUIDELINE_001",
  "participants": "Evidence-based guideline",
  "year": 2022,
  "notes": "ASCO Guideline: Medical Cannabis in Oncology",
  "confidence": "medium",
  "abstract": "Recommendations: May discuss cannabis with patients; Evidence supports use for refractory symptoms; Start low/go slow dosing; Monitor for interactions"
}